(Q24201642)

2

0 references

Silvia Minozzi

1

0 references

Cristina Bellisario

object named as

Cristina Bellisario

3

0 references

author name string

Marica Ferri

Cochrane Database of Systematic Reviews

4

0 references

publication date

23 December 2013

0 references

published in

0 references

cites work

Comparison of methadone and slow-release morphine maintenance in pregnant addicts.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

A comparison of cigarette smoking profiles in opioid-dependent pregnant patients receiving methadone or buprenorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Neonatal neurobehavior effects following buprenorphine versus methadone exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Infections and obstetric outcomes in opioid-dependent pregnant women maintained on methadone or buprenorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Fetal neurobehavioral effects of exposure to methadone or buprenorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Maternal Opioid Treatment: Human Experimental Research (MOTHER)--approach, issues and lessons learned

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Neonatal abstinence syndrome after methadone or buprenorphine exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Are male neonates more vulnerable to neonatal abstinence syndrome than female neonates?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Lessons learned from a comparison of evidence-based research in pregnant opioid-dependent women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Maternal Opioid Treatment: Human Experimental Research (MOTHER) Study: maternal, fetal and neonatal outcomes from secondary analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Dihydrocodeine as effective as methadone for maintenance of treatment for opiate dependence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Reducing potential for child abuse among methadone-maintained parents: results from a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Management of neonatal abstinence syndrome in neonates born to opioid maintained women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

A randomised controlled trial of morphine versus phenobarbitone for neonatal abstinence syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Treatment of opioid-dependent pregnant women: clinical and research issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Reinforcement-based treatment improves the maternal treatment and neonatal outcomes of pregnant patients enrolled in comprehensive care treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Predictors of prenatal substance use and birth weight during outpatient treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Characteristics of opioid-using pregnant women who accept or refuse participation in a clinical trial: screening results from the MOTHER study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Lessons learned from a randomized trial of fixed and escalating contingency management schedules in opioid-dependent pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Methadone maintenance in pregnancy: a reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

LAAM maintenance vs methadone maintenance for heroin dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Methadone maintenance at different dosages for opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Pregnancy outcome in women who use opiates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Heroin maintenance for chronic heroin-dependent individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Grading quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Assessing the relationship between maternal opiate use and neonatal mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Use of buprenorphine in pregnancy: patient management and effects on the neonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Opioid dependence during pregnancy. Effects and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenophine substitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Obstetric and perinatal outcomes in pregnancies associated with illicit substance abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Psychosocial treatment for opiate abuse and dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Oral naltrexone maintenance treatment for opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Pharmacotherapy for pregnant women with addictions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Methadone treatment during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

Methadone maintenance vs. implantable naltrexone treatment in the pregnant heroin user

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

7 January 2021

Methadone treatment during pregnancy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

7 January 2021

Response to "Methadone Maintenance vs. Methadone Taper during Pregnancy" Paper

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

7 January 2021

Buprenorphine maintenance in pregnant opiate addicts

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

7 January 2021

An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006318.PUB3

7 January 2021

10.1002/14651858.CD006318.PUB3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

24366859

1 reference

Consolidated OpenCitations Corpus – April 2017